Antiepileptic treatment in patients with intellectual disabilities: Experience from the 1980s - Challenge in the 1990s;Behandling med antiepileptika hos pasienter med psykisk utviklingshemning: Erfaring fra 1980-årene gir utfordring i 1990-årene

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 3, 1996, Pages 387-391

  Brodtkorb, Eylert ^a  

^a Nevrologisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; AGED; ARTICLE; DISABILITY; DRUG PREFERENCE; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; PATIENT MONITORING; PRESCRIPTION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; DRUG UTILIZATION; EPILEPSY, GENERALIZED; HISTORY, 20TH CENTURY; HUMANS; MENTAL RETARDATION; MIDDLE AGED; NORWAY;

EID: 0030052872     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Forsgren L, Edvinsson S-O, Blomquist HK, Heijbel I, Sidenvall R. Epilepsy in a population of mentally retarded children and adults. Epilepsy Res 1990; 6: 234-48.
2. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313: 145-51.
3. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized seizures in adults. N Engl J Med 1992; 327: 765-71.
4. Callaghan N, Kenny RA, O'Neill B, Crowley M, Goggin T. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry 1985; 48: 639-44.
5. Smith DB, Mattson RH, Cramer JA, Collins JF, Novelly RA, Craft B and the Veterans Administration Epilepsy Cooperative Study Group. Results of a nationwide Veterans Administration cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 1987; 28 (suppl 3): 50-8.
6. Chadwick D. Standard approach to antiepileptic drug treatment in the United Kingdom. Epilepsia 1994; 35 (suppl 4): 3-10.
7. Smith DB. Cognitive effects of antiepileptic drugs. I: Smith D, Treiman D, Trimble M, red. Advances in neurology. Bd. 55. New York: Raven Press, 1991: 197-212.
8. Anatomical Therapeutic Chemical (ATC) Classification index including defined daily doses (DDDs) for plain substances. Oslo. WHO Collaborating Centre for Drug Statistics Methodology, 1993.
9. Hauser WA. The natural history of seizures. I: Wyllie E, red. The treatment of epilepsy, principles and practice. Philadelphia: Lea & Fabiger 1993, 165-70.
10. Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy? Epilepsia 1981. 22: 1-10.
11. Brodtkorb E. The diversity of epilepsy in adults with severe developmental disabilities: age at seizure onset and other prognostic factors. Seizure 1994; 3: 277-85.